SE512871C2 - Oftalmologisk beredning innehållande pilokarpin och ytterligare medel för behandling av okular hypertension - Google Patents

Oftalmologisk beredning innehållande pilokarpin och ytterligare medel för behandling av okular hypertension

Info

Publication number: SE512871C2
Authority: SE; Sweden
Prior art keywords: formulation according; pilocarpine; viscosity; mpas; formulation
Prior art date: 1992-08-20

Application number

SE9202398A

Other languages

English (en)

Swedish (sv)

Other versions

SE9202398D0 (sv

SE9202398L (sv

Inventor

Kari Lehmussaari

Olli Oksala

Timo Reunamoeki

Original Assignee

Santen Oy

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-08-20

Filing date

1992-08-20

Publication date

2000-05-29

1992-08-20 Application filed by Santen Oy filed Critical Santen Oy

1992-08-20 Priority to SE9202398A priority Critical patent/SE512871C2/sv

1992-08-20 Publication of SE9202398D0 publication Critical patent/SE9202398D0/xx

1993-08-17 Priority to TW082106600A priority patent/TW427913B/zh

1993-08-18 Priority to EP93917820A priority patent/EP0655911B1/en

1993-08-18 Priority to PCT/FI1993/000326 priority patent/WO1994004134A1/en

1993-08-18 Priority to HU9500501A priority patent/HU226829B1/hu

1993-08-18 Priority to AT93917820T priority patent/ATE175867T1/de

1993-08-18 Priority to SG1996005479A priority patent/SG49041A1/en

1993-08-18 Priority to RU9595109145A priority patent/RU2099049C1/ru

1993-08-18 Priority to DE69323202T priority patent/DE69323202T2/de

1993-08-18 Priority to CZ95414A priority patent/CZ283895B6/cs

1993-08-18 Priority to JP6505943A priority patent/JPH08500354A/ja

1993-08-18 Priority to RO95-00317A priority patent/RO111988B1/ro

1993-08-18 Priority to DE0655911T priority patent/DE655911T1/de

1993-08-18 Priority to KR1019950700483A priority patent/KR100295407B1/ko

1993-08-18 Priority to AU47117/93A priority patent/AU674335B2/en

1993-08-18 Priority to PL93307526A priority patent/PL175860B1/pl

1993-08-18 Priority to HK98115148.2A priority patent/HK1013955B/en

1993-08-18 Priority to DK93917820T priority patent/DK0655911T3/da

1993-08-18 Priority to ES93917820T priority patent/ES2080031T3/es

1993-08-18 Priority to SK209-95A priority patent/SK281092B6/sk

1993-08-18 Priority to BR9307099A priority patent/BR9307099A/pt

1993-08-19 Priority to MX9305043A priority patent/MX9305043A/es

1993-08-19 Priority to CN93116550A priority patent/CN1041795C/zh

1993-08-19 Priority to ZA936094A priority patent/ZA936094B/xx

1994-02-21 Publication of SE9202398L publication Critical patent/SE9202398L/xx

1994-10-28 Priority to EE9400263A priority patent/EE03188B1/xx

1995-02-15 Priority to FI950682A priority patent/FI111334B/fi

1995-02-17 Priority to NO950595A priority patent/NO307952B1/no

1995-03-08 Priority to BG99483A priority patent/BG62381B1/bg

1995-10-13 Priority to US08/542,714 priority patent/US5767143A/en

1996-02-29 Priority to GR960300003T priority patent/GR960300003T1/el

1999-04-19 Priority to GR990401071T priority patent/GR3029992T3/el

2000-05-29 Publication of SE512871C2 publication Critical patent/SE512871C2/sv

Links

QCHFTSOMWOSFHM-WPRPVWTQSA-N (+)-Pilocarpine Chemical compound C1OC(=O)[C@@H](CC)[C@H]1CC1=CN=CN1C QCHFTSOMWOSFHM-WPRPVWTQSA-N 0.000 title claims abstract description 12
QCHFTSOMWOSFHM-UHFFFAOYSA-N SJ000285536 Natural products C1OC(=O)C(CC)C1CC1=CN=CN1C QCHFTSOMWOSFHM-UHFFFAOYSA-N 0.000 title claims abstract description 12
229960001416 pilocarpine Drugs 0.000 title claims abstract description 12
238000002360 preparation method Methods 0.000 title claims description 9
206010030043 Ocular hypertension Diseases 0.000 title claims description 8
239000000203 mixture Substances 0.000 claims abstract description 32
238000009472 formulation Methods 0.000 claims abstract description 27
239000003889 eye drop Substances 0.000 claims abstract description 12
239000002876 beta blocker Substances 0.000 claims abstract description 3
229940097320 beta blocking agent Drugs 0.000 claims abstract description 3
229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 9
235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 9
239000003795 chemical substances by application Substances 0.000 claims description 8
TWBNMYSKRDRHAT-RCWTXCDDSA-N (S)-timolol hemihydrate Chemical compound O.CC(C)(C)NC[C@H](O)COC1=NSN=C1N1CCOCC1.CC(C)(C)NC[C@H](O)COC1=NSN=C1N1CCOCC1 TWBNMYSKRDRHAT-RCWTXCDDSA-N 0.000 claims description 7
WLRMANUAADYWEA-NWASOUNVSA-N (S)-timolol maleate Chemical compound OC(=O)\C=C/C(O)=O.CC(C)(C)NC[C@H](O)COC1=NSN=C1N1CCOCC1 WLRMANUAADYWEA-NWASOUNVSA-N 0.000 claims description 6
229960004605 timolol Drugs 0.000 claims description 6
229960005221 timolol maleate Drugs 0.000 claims description 6
239000002671 adjuvant Substances 0.000 claims description 4
239000007979 citrate buffer Substances 0.000 claims description 3
239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 3
UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 3
238000000034 method Methods 0.000 claims description 3
-1 timolol compound Chemical class 0.000 claims description 3
239000000872 buffer Substances 0.000 claims description 2
239000002552 dosage form Substances 0.000 claims description 2
239000002981 blocking agent Substances 0.000 claims 3
229960000454 timolol hemihydrate Drugs 0.000 claims 1
229920000642 polymer Polymers 0.000 abstract description 4
239000000243 solution Substances 0.000 description 23
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
239000008223 sterile water Substances 0.000 description 10
RNAICSBVACLLGM-GNAZCLTHSA-N pilocarpine hydrochloride Chemical compound Cl.C1OC(=O)[C@@H](CC)[C@H]1CC1=CN=CN1C RNAICSBVACLLGM-GNAZCLTHSA-N 0.000 description 9
YASYEJJMZJALEJ-UHFFFAOYSA-N Citric acid monohydrate Chemical compound O.OC(=O)CC(O)(C(O)=O)CC(O)=O YASYEJJMZJALEJ-UHFFFAOYSA-N 0.000 description 6
229960002303 citric acid monohydrate Drugs 0.000 description 6
229960000999 sodium citrate dihydrate Drugs 0.000 description 6
HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 6
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 4
229960000686 benzalkonium chloride Drugs 0.000 description 4
CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 4
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
229920002125 Sokalan® Polymers 0.000 description 3
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
230000007423 decrease Effects 0.000 description 3
239000013022 formulation composition Substances 0.000 description 3
229920002451 polyvinyl alcohol Polymers 0.000 description 3
239000003755 preservative agent Substances 0.000 description 3
239000000126 substance Substances 0.000 description 3
229920002307 Dextran Polymers 0.000 description 2
WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
230000000845 anti-microbial effect Effects 0.000 description 2
229960004324 betaxolol Drugs 0.000 description 2
CHDPSNLJFOQTRK-UHFFFAOYSA-N betaxolol hydrochloride Chemical compound [Cl-].C1=CC(OCC(O)C[NH2+]C(C)C)=CC=C1CCOCC1CC1 CHDPSNLJFOQTRK-UHFFFAOYSA-N 0.000 description 2
OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 2
239000003814 drug Substances 0.000 description 2
229940079593 drug Drugs 0.000 description 2
230000007935 neutral effect Effects 0.000 description 2
235000019422 polyvinyl alcohol Nutrition 0.000 description 2
235000002639 sodium chloride Nutrition 0.000 description 2
108060003345 Adrenergic Receptor Proteins 0.000 description 1
102000017910 Adrenergic receptor Human genes 0.000 description 1
BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
208000035473 Communicable disease Diseases 0.000 description 1
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
208000003556 Dry Eye Syndromes Diseases 0.000 description 1
206010013774 Dry eye Diseases 0.000 description 1
208000010412 Glaucoma Diseases 0.000 description 1
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
229930195725 Mannitol Natural products 0.000 description 1
229920003091 Methocel™ Polymers 0.000 description 1
WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
229920003072 Plasdone™ povidone Polymers 0.000 description 1
239000004372 Polyvinyl alcohol Substances 0.000 description 1
VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
239000008351 acetate buffer Substances 0.000 description 1
DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
239000002253 acid Substances 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
239000013543 active substance Substances 0.000 description 1
229940006133 antiglaucoma drug and miotics carbonic anhydrase inhibitors Drugs 0.000 description 1
239000004599 antimicrobial Substances 0.000 description 1
229940027983 antiseptic and disinfectant quaternary ammonium compound Drugs 0.000 description 1
238000013459 approach Methods 0.000 description 1
229960004374 befunolol Drugs 0.000 description 1
ZPQPDBIHYCBNIG-UHFFFAOYSA-N befunolol Chemical compound CC(C)NCC(O)COC1=CC=CC2=C1OC(C(C)=O)=C2 ZPQPDBIHYCBNIG-UHFFFAOYSA-N 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
229910021538 borax Inorganic materials 0.000 description 1
239000006172 buffering agent Substances 0.000 description 1
239000003489 carbonate dehydratase inhibitor Substances 0.000 description 1
239000001768 carboxy methyl cellulose Substances 0.000 description 1
229960001222 carteolol Drugs 0.000 description 1
LWAFSWPYPHEXKX-UHFFFAOYSA-N carteolol Chemical compound N1C(=O)CCC2=C1C=CC=C2OCC(O)CNC(C)(C)C LWAFSWPYPHEXKX-UHFFFAOYSA-N 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
229960003260 chlorhexidine Drugs 0.000 description 1
229960004926 chlorobutanol Drugs 0.000 description 1
229960004106 citric acid Drugs 0.000 description 1
238000011109 contamination Methods 0.000 description 1
210000004087 cornea Anatomy 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
230000000694 effects Effects 0.000 description 1
238000001914 filtration Methods 0.000 description 1
235000011187 glycerol Nutrition 0.000 description 1
239000012456 homogeneous solution Substances 0.000 description 1
239000000314 lubricant Substances 0.000 description 1
239000000594 mannitol Substances 0.000 description 1
235000010355 mannitol Nutrition 0.000 description 1
229920000609 methyl cellulose Polymers 0.000 description 1
YLGXILFCIXHCMC-JHGZEJCSSA-N methyl cellulose Chemical compound COC1C(OC)C(OC)C(COC)O[C@H]1O[C@H]1C(OC)C(OC)C(OC)OC1COC YLGXILFCIXHCMC-JHGZEJCSSA-N 0.000 description 1
239000001923 methylcellulose Substances 0.000 description 1
230000000813 microbial effect Effects 0.000 description 1
238000002156 mixing Methods 0.000 description 1
239000003960 organic solvent Substances 0.000 description 1
229940094443 oxytocics prostaglandins Drugs 0.000 description 1
238000012536 packaging technology Methods 0.000 description 1
239000008363 phosphate buffer Substances 0.000 description 1
229960002139 pilocarpine hydrochloride Drugs 0.000 description 1
229960002508 pindolol Drugs 0.000 description 1
PHUTUTUABXHXLW-UHFFFAOYSA-N pindolol Chemical compound CC(C)NCC(O)COC1=CC=CC2=NC=C[C]12 PHUTUTUABXHXLW-UHFFFAOYSA-N 0.000 description 1
229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
239000001267 polyvinylpyrrolidone Substances 0.000 description 1
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
239000011148 porous material Substances 0.000 description 1
239000001103 potassium chloride Substances 0.000 description 1
235000011164 potassium chloride Nutrition 0.000 description 1
230000002335 preservative effect Effects 0.000 description 1
229940002612 prodrug Drugs 0.000 description 1
239000000651 prodrug Substances 0.000 description 1
150000003180 prostaglandins Chemical class 0.000 description 1
150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
239000001632 sodium acetate Substances 0.000 description 1
235000017281 sodium acetate Nutrition 0.000 description 1
235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
239000001509 sodium citrate Substances 0.000 description 1
229960001790 sodium citrate Drugs 0.000 description 1
235000010339 sodium tetraborate Nutrition 0.000 description 1
239000000600 sorbitol Substances 0.000 description 1
235000010356 sorbitol Nutrition 0.000 description 1
230000000087 stabilizing effect Effects 0.000 description 1
238000003756 stirring Methods 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 1
229960004906 thiomersal Drugs 0.000 description 1
BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics

Landscapes

Health & Medical Sciences (AREA)
Ophthalmology & Optometry (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Laser Surgery Devices (AREA)
Radiation-Therapy Devices (AREA)

SE9202398A 1992-08-20 1992-08-20 Oftalmologisk beredning innehållande pilokarpin och ytterligare medel för behandling av okular hypertension SE512871C2 (sv)

Priority Applications (31)

Application Number	Priority Date	Filing Date	Title
SE9202398A SE512871C2 (sv)	1992-08-20	1992-08-20	Oftalmologisk beredning innehållande pilokarpin och ytterligare medel för behandling av okular hypertension
TW082106600A TW427913B (en)	1992-08-20	1993-08-17	Eye drop composition comprising pilocarpine and a β-blocking agent and process making the same
BR9307099A BR9307099A (pt)	1992-08-20	1993-08-18	Formulação de colírio processo para preparar uma formulação de colírio e processo de tratamento de hipertensão ocular e glaucoma
AU47117/93A AU674335B2 (en)	1992-08-20	1993-08-18	Ophthalmological preparation
DK93917820T DK0655911T3 (da)	1992-08-20	1993-08-18	Opthalmologisk præparat
HU9500501A HU226829B1 (en)	1992-08-20	1993-08-18	Ophthalmological preparation and process for producing them
AT93917820T ATE175867T1 (de)	1992-08-20	1993-08-18	Ophthalmologische zubereitungen
SG1996005479A SG49041A1 (en)	1992-08-20	1993-08-18	Ophthalmological preparation
RU9595109145A RU2099049C1 (ru)	1992-08-20	1993-08-18	Капли для лечения глазной гипертензии и глаукомы и способ их получения
DE69323202T DE69323202T2 (de)	1992-08-20	1993-08-18	Ophthalmologische zubereitungen
CZ95414A CZ283895B6 (cs)	1992-08-20	1993-08-18	Preparát očních kapek a způsob jeho přípravy
JP6505943A JPH08500354A (ja)	1992-08-20	1993-08-18	眼科治療用製剤
RO95-00317A RO111988B1 (ro)	1992-08-20	1993-08-18	Preparat oftalmologic
DE0655911T DE655911T1 (de)	1992-08-20	1993-08-18	Ophthalmologische zubereitungen.
KR1019950700483A KR100295407B1 (ko)	1992-08-20	1993-08-18	안약배합물
EP93917820A EP0655911B1 (en)	1992-08-20	1993-08-18	Ophthalmological preparation
PL93307526A PL175860B1 (pl)	1992-08-20	1993-08-18	Preparat w postaci kropli do oczu i sposób wytwarzania preparatu w postaci kropli do oczu.
HK98115148.2A HK1013955B (en)	1992-08-20	1993-08-18	Ophthalmological preparation
PCT/FI1993/000326 WO1994004134A1 (en)	1992-08-20	1993-08-18	Ophthalmological preparation
ES93917820T ES2080031T3 (es)	1992-08-20	1993-08-18	Preparacion oftalmologica.
SK209-95A SK281092B6 (sk)	1992-08-20	1993-08-18	Preparát očných kvapiek
ZA936094A ZA936094B (en)	1992-08-20	1993-08-19	Ophthalmological preparation.
MX9305043A MX9305043A (es)	1992-08-20	1993-08-19	Preparacion oftalmologica.
CN93116550A CN1041795C (zh)	1992-08-20	1993-08-19	眼用组合物
EE9400263A EE03188B1 (et)	1992-08-20	1994-10-28	Oftalmoloogiline preparaat ja selle valmistamise meetod
FI950682A FI111334B (fi)	1992-08-20	1995-02-15	Menetelmä silmätippavalmisteen valmistamiseksi
NO950595A NO307952B1 (no)	1992-08-20	1995-02-17	Oftalmologisk preparat samt fremgangsmÕte til fremstilling derav
BG99483A BG62381B1 (bg)	1992-08-20	1995-03-08	Офталмологичен препарат
US08/542,714 US5767143A (en)	1992-08-20	1995-10-13	Ophthalmological preparation
GR960300003T GR960300003T1 (en)	1992-08-20	1996-02-29	Ophthalmological preparation.
GR990401071T GR3029992T3 (en)	1992-08-20	1999-04-19	Ophthalmological preparation.

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE9202398A SE512871C2 (sv)	1992-08-20	1992-08-20	Oftalmologisk beredning innehållande pilokarpin och ytterligare medel för behandling av okular hypertension

Publications (3)

Publication Number	Publication Date
SE9202398D0 SE9202398D0 (sv)	1992-08-20
SE9202398L SE9202398L (sv)	1994-02-21
SE512871C2 true SE512871C2 (sv)	2000-05-29

Family

ID=20386970

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE9202398A SE512871C2 (sv)	1992-08-20	1992-08-20	Oftalmologisk beredning innehållande pilokarpin och ytterligare medel för behandling av okular hypertension

Country Status (26)

Country	Link
US (1)	US5767143A (da)
EP (1)	EP0655911B1 (da)
JP (1)	JPH08500354A (da)
KR (1)	KR100295407B1 (da)
CN (1)	CN1041795C (da)
AT (1)	ATE175867T1 (da)
AU (1)	AU674335B2 (da)
BG (1)	BG62381B1 (da)
BR (1)	BR9307099A (da)
CZ (1)	CZ283895B6 (da)
DE (2)	DE69323202T2 (da)
DK (1)	DK0655911T3 (da)
EE (1)	EE03188B1 (da)
ES (1)	ES2080031T3 (da)
GR (2)	GR960300003T1 (da)
HU (1)	HU226829B1 (da)
MX (1)	MX9305043A (da)
NO (1)	NO307952B1 (da)
PL (1)	PL175860B1 (da)
RO (1)	RO111988B1 (da)
SE (1)	SE512871C2 (da)
SG (1)	SG49041A1 (da)
SK (1)	SK281092B6 (da)
TW (1)	TW427913B (da)
WO (1)	WO1994004134A1 (da)
ZA (1)	ZA936094B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1230882A (zh) *	1996-09-20	1999-10-06	博士伦公司	再湿润隐形眼镜和减轻眼部干燥的方法和组合物
US6645963B2 (en)	1997-11-05	2003-11-11	Senju Pharmaceutical Co., Ltd.	Prolonged-action eye drop
CN1124842C (zh) *	1997-11-05	2003-10-22	千寿制药株式会社	缓释滴眼剂
MY116782A (en) *	1997-12-22	2004-03-31	Otsuka Pharma Co Ltd	Water-soluble eye drop
JP5364658B2 (ja) *	2000-07-21	2013-12-11	ロート製薬株式会社	点眼剤
JP2005247875A (ja) *	2000-07-21	2005-09-15	Rohto Pharmaceut Co Ltd	点眼剤
JP2002097129A (ja) *	2000-07-21	2002-04-02	Rohto Pharmaceut Co Ltd	点眼剤
AU2002245134A1 (en) *	2000-12-21	2002-08-06	Alcon Universal Ltd.	Artificial tear composition adapted to be used with contact lenses
CN100483106C (zh) *	2002-09-29	2009-04-29	天津市先石光学技术有限公司	可分离介质表层与深层信息的光学检测方法
US7862552B2 (en)	2005-05-09	2011-01-04	Boston Scientific Scimed, Inc.	Medical devices for treating urological and uterine conditions
CA2717825A1 (en) *	2008-03-07	2009-09-11	Sun Pharma Advanced Research Company Ltd.	Opthalmic composition
RU2402316C2 (ru) *	2009-01-11	2010-10-27	Пшеничников Виталий Георгиевич	Фармацевтическая антиглаукомная композиция
EP3517111A3 (en)	2011-09-20	2019-12-11	Allergan, Inc.	Compositions and methods for treating presbyopia, mild hyperopia, and irregular astigmatism
CA3162141A1 (en)	2018-04-24	2019-10-31	Allergan, Inc.	Presbyopia treatments
KR20250019688A (ko) *	2022-06-03	2025-02-10	에이엠디 세러퓨틱스 엘엘씨	리파마이신 안과용 조성물 및 이의 용도

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2601247A1 (fr) *	1986-07-09	1988-01-15	Merk Sharp Dohme Chibret Labor	Combinaison d'agents beta-bloquants et de pilocarpine.
US5252318A (en) *	1990-06-15	1993-10-12	Allergan, Inc.	Reversible gelation compositions and methods of use

1992
- 1992-08-20 SE SE9202398A patent/SE512871C2/sv not_active IP Right Cessation
1993
- 1993-08-17 TW TW082106600A patent/TW427913B/zh not_active IP Right Cessation
- 1993-08-18 KR KR1019950700483A patent/KR100295407B1/ko not_active Expired - Fee Related
- 1993-08-18 HU HU9500501A patent/HU226829B1/hu unknown
- 1993-08-18 AT AT93917820T patent/ATE175867T1/de active
- 1993-08-18 DE DE69323202T patent/DE69323202T2/de not_active Expired - Lifetime
- 1993-08-18 BR BR9307099A patent/BR9307099A/pt not_active Application Discontinuation
- 1993-08-18 WO PCT/FI1993/000326 patent/WO1994004134A1/en not_active Ceased
- 1993-08-18 DK DK93917820T patent/DK0655911T3/da active
- 1993-08-18 SG SG1996005479A patent/SG49041A1/en unknown
- 1993-08-18 SK SK209-95A patent/SK281092B6/sk unknown
- 1993-08-18 ES ES93917820T patent/ES2080031T3/es not_active Expired - Lifetime
- 1993-08-18 EP EP93917820A patent/EP0655911B1/en not_active Expired - Lifetime
- 1993-08-18 PL PL93307526A patent/PL175860B1/pl unknown
- 1993-08-18 JP JP6505943A patent/JPH08500354A/ja active Pending
- 1993-08-18 CZ CZ95414A patent/CZ283895B6/cs not_active IP Right Cessation
- 1993-08-18 AU AU47117/93A patent/AU674335B2/en not_active Ceased
- 1993-08-18 RO RO95-00317A patent/RO111988B1/ro unknown
- 1993-08-18 DE DE0655911T patent/DE655911T1/de active Pending
- 1993-08-19 MX MX9305043A patent/MX9305043A/es unknown
- 1993-08-19 ZA ZA936094A patent/ZA936094B/xx unknown
- 1993-08-19 CN CN93116550A patent/CN1041795C/zh not_active Expired - Fee Related
1994
- 1994-10-28 EE EE9400263A patent/EE03188B1/xx unknown
1995
- 1995-02-17 NO NO950595A patent/NO307952B1/no not_active IP Right Cessation
- 1995-03-08 BG BG99483A patent/BG62381B1/bg unknown
- 1995-10-13 US US08/542,714 patent/US5767143A/en not_active Expired - Fee Related
1996
- 1996-02-29 GR GR960300003T patent/GR960300003T1/el unknown
1999
- 1999-04-19 GR GR990401071T patent/GR3029992T3/el unknown

Also Published As

Publication number	Publication date
CZ41495A3 (en)	1995-10-18
CN1041795C (zh)	1999-01-27
MX9305043A (es)	1994-02-28
GR3029992T3 (en)	1999-07-30
BG99483A (bg)	1995-12-29
SK20995A3 (en)	1997-01-08
SE9202398D0 (sv)	1992-08-20
SG49041A1 (en)	1998-05-18
CZ283895B6 (cs)	1998-07-15
HUT71897A (en)	1996-02-28
ATE175867T1 (de)	1999-02-15
DK0655911T3 (da)	1999-09-13
ES2080031T1 (es)	1996-02-01
HU226829B1 (en)	2009-11-30
US5767143A (en)	1998-06-16
HK1013955A1 (en)	1999-09-17
SK281092B6 (sk)	2000-11-07
AU674335B2 (en)	1996-12-19
PL175860B1 (pl)	1999-02-26
GR960300003T1 (en)	1996-02-29
BG62381B1 (bg)	1999-10-29
BR9307099A (pt)	1999-06-01
DE655911T1 (de)	1996-02-29
KR100295407B1 (ko)	2001-09-17
EP0655911A1 (en)	1995-06-07
NO307952B1 (no)	2000-06-26
RO111988B1 (ro)	1997-04-30
EP0655911B1 (en)	1999-01-20
NO950595L (no)	1995-02-17
DE69323202D1 (de)	1999-03-04
WO1994004134A1 (en)	1994-03-03
ES2080031T3 (es)	1999-05-01
SE9202398L (sv)	1994-02-21
PL307526A1 (en)	1995-05-29
CN1089837A (zh)	1994-07-27
AU4711793A (en)	1994-03-15
NO950595D0 (no)	1995-02-17
TW427913B (en)	2001-04-01
ZA936094B (en)	1994-03-28
HU9500501D0 (en)	1995-04-28
EE03188B1 (et)	1999-06-15
JPH08500354A (ja)	1996-01-16
DE69323202T2 (de)	1999-07-01

Legal Events

Date	Code	Title	Description
2006-04-25	NUG	Patent has lapsed

Publication	Publication Date	Title
SE512871C2 (sv)	2000-05-29	Oftalmologisk beredning innehållande pilokarpin och ytterligare medel för behandling av okular hypertension
JP2017531045A (ja)	2017-10-19	眼科用液剤
HU226613B1 (en)	2009-04-28	Aqueous suspension for nasal administration containing lotepredol as active ingredient
JP2023029543A (ja)	2023-03-03	眼科用組成物その３
JP6672512B2 (ja)	2020-03-25	一酸化窒素放出プロスタミドを含有する眼科用組成物
JP6495379B2 (ja)	2019-04-03	水性の組成物
JP2001081048A (ja)	2001-03-27	眼圧降下剤
EP0577913B1 (en)	1997-06-18	Ophthalmic composition containing timolol hemihydrate
RU2099049C1 (ru)	1997-12-20	Капли для лечения глазной гипертензии и глаукомы и способ их получения
EP4230193A1 (en)	2023-08-23	Ophthalmic pharmaceutical composition
JP2017226651A (ja)	2017-12-28	水性なる組成物
FI111334B (fi)	2003-07-15	Menetelmä silmätippavalmisteen valmistamiseksi
JP5695580B2 (ja)	2015-04-08	ラタノプロストのバイオアベイラビリティを向上させる方法
HK1013955B (en)	2000-06-23	Ophthalmological preparation
JP2016113459A (ja)	2016-06-23	水性である組成物
CA2142817A1 (en)	1994-03-03	Ophthalmological preparation
HK1059573A1 (en)	2004-07-09	Olopatadine formulations for topical administration